arrow_back Civic Audit
Share share

GAP Supply Act: Amending Drug Shortage Regulations

This bill amends section 503B of the Federal Food, Drug, and Cosmetic Act. It allows outsourcing facilities to compound and distribute drugs for 180 days after a drug has been on a shortage list, rather than requiring the drug to be in shortage at the specific time of distribution.
Key points
Changes the timing requirement from 'at the time' to 'within 180 calendar days' regarding drug shortages.
Allows outsourcing facilities a tail period to continue supplying the market after a drug shortage.
Amends section 503B of the Federal Food, Drug, and Cosmetic Act.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_7528
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
Process start date: 2026-02-12
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

GAP Supply Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_7528.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-02-12.

What are the main provisions?

Key points include:

  • Changes the timing requirement from 'at the time' to 'within 180 calendar days' regarding drug shortages.
  • Allows outsourcing facilities a tail period to continue supplying the market after a drug shortage.
  • Amends section 503B of the Federal Food, Drug, and Cosmetic Act.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Carter, Earl L. "Buddy" [R-GA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-02-26.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health